Sintesis 1,4-Di-(Indol-3-Karbaldehida-1-Ilmetil)Benzena dan 1,4-Di-(Indol-3-Hidroksimetil-1-Ilmetil)Benzena

Abstract

Senyawa heterosiklik yang mengandung atom nitrogen merupakan senyawa penting dalam bidang kimia obat, diantaranya adalah indol dan turunannya yang dilaporkan mempunyai bioaktivitas anti-kanker. Sehubungan dengan hasil studi literatur maka dapat dibuat hipotesa bahwa 1,4-di-(indol-3-karbaldehida-1-ilmetil)benzena dan 1,4-di-(indol-3-hidroksimetil-1-ilmetil)benzena lebih mempunyai aktivitas anti-kanker. Penelitian yang dilakukan berhasil mensintesis indol-3-karboksaldehida dan natrium hidrida dalam asetonitril diperoleh 1,4-di-(indol-3-karbaldehida-1-ilmetil)benzena dengan rendemen 99%. Reduksi 1,4-di-(indol-3-karbaldehida-1-ilmetil)benzena dengan natrium borohidrida dalam etanol diperoleh 1,4-di-(indol-3-hidroksimetil-1-ilmetil)benzena dengan rendemen 80%. Struktur senyawa dari hasil sintesis ditentukan dengan spektrometer NMR dan IR. ================================================================= Heterocyclic compounds containing nitrogen atoms are important compounds in the chemical field of drugs, including indol and its derivatives are reported to have anti-cancer bioactivity. Based on the results of the literature study it can be hypothesized that 1,4-di- (indol-3-carbaldehyde-1-ilmethyl) benzene and 1,4-di- (indol-3-hydroxymethyl-1-ilmethyl) benzene have anticancer activity higher. The results showed 1.4-di- (indol-3-carbaldehyde-1-ilmethyl) benzene was obtained from the reaction between indole-3-carboxboxehyde and sodium hydride in acetonitrile with 99% yield. 1,4-di- (indol-3-hydroxymethyl-1-ilmethyl) benzene was obtained from the reduction of 1,4-di- (indol-3-carbaldehyde-1-ilmethyl) benzene process with sodium borohydride in ethanol with a yield of 80%. The structure of the compound of the synthesis product is determined by the NMR and IR spectrometers

Similar works

This paper was published in ITS Repository.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.